The standard treatment for Type 1 Diabetes Mellitusstill involves daily parenteral insulin administration, which presentsseveral challenges including patient discomfort, reduced adherence,and the potential for peripheral hyperinsulinemia. Here, INS is linked to Hyperinsulinemia.